3-Bromo-4-methylpyridin-2-ol

Catalog No. :
ACJELY639
CAS No. :
18368-59-7
Molecular Formula :
C6H6BrNO
Molecular Weight :
188.02

IUPAC Name:3-bromo-4-methylpyridin-2-ol

3-Bromo-4-methylpyridin-2-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$56.00Login to see priceIn stockInquiry
25g98%$181.00Login to see priceIn stockInquiry
100g98%$721.00Login to see priceIn stockInquiry
500g98%$3461.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-4-methylpyridin-2-ol
IUPAC Name3-bromo-4-methylpyridin-2-ol
MDL No.MFCD02181071
Molecular FormulaC6H6BrNO
Molecular Weight188.02
SMILESCC1=C(Br)C(O)=NC=C1
InChI KeyDDRFLSCTQJTMAA-UHFFFAOYSA-N
Synonym18368-59-7 | 3-bromo-4-methylpyridin-2-ol | 2-HYDROXY-3-BROMO-4-METHYLPYRIDINE | 3-Bromo-4-methylpyridin-2(1H)-one | 3-Bromo-2-hydroxy-4-picoline | 3-Bromo-2-hydroxy-4-methylpyridine | 3-BROMO-4-METHYL-1H-PYRIDIN-2-ONE | 3-Bromo-4-methyl-2-(1H)-pyridinone | 2(1H)-Pyridin
CAS No.18368-59-7
PubChem CID13463813

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJELY639 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAVEP561 route compound structure diagram
    ACAVEP56155404-31-4 In Stock
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2 In Stock
  4. Then
  5. ACJELY639 route product structure diagram
    ACJELY63918368-59-7 In Stock
Inquiry

2. ACJELY639 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLXIF856 route compound structure diagram
    ACLXIF85613466-41-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJELY639 route product structure diagram
    ACJELY63918368-59-7 In Stock
Inquiry

Comments (0)